Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RECTRON Interim / Quarterly Report 2024

Dec 23, 2024

51998_rns_2024-12-23_2da68f39-3e83-4f7f-b701-c6549b121172.pdf

Interim / Quarterly Report

Open in viewer

Opens in your device viewer

1

Stock Code:2302

Rectron Ltd. AND SUBSIDIARIES

Consolidated Financial Statements

With Independent Auditors’ Review Report For the Three Months Ended March 31, 2024 and 2023

Address: No. 71, Zhongshan Rd., Tucheng Dist., New Taipei City, Taiwan Telephone: 886-2-28801122

The independent auditors’ review report and the accompanying consolidated financial statements are the English translation of the Chinese version prepared and used in the Republic of China. If there is any conflict between, or any difference in the interpretation of the English and Chinese language independent auditors’ review report and consolidated financial statements, the Chinese version shall prevail.

2

Table of contents


Contents
1.Cover Page
2.Table of Contents
3.Independent Auditors’ Review Report
4.Consolidated Balance Sheets
5.Consolidated Statement of Comprehensive Income
6.Consolidated Statement of Changes in Equity
7.Consolidated Statement of Cash Flows
8.Notes to the Consolidated Financial Statements
(1) Company history
(2) Approval date and procedures of the consolidated financial statements
(3) New standards, amendments and interpretations adopted
(4) Summary of significant accounting policies
(5) Significant accounting assumptions and judgments, and major sources of
estimation uncertainty
(6) Explanation of significant accounts
(7) Related-party transactions
(8) Assets pledged as security
(9) Commitments and contingencies
(10) Losses due to major disasters
(11) Subsequent events
(12) Other
(13) Other disclosures
 Information on significant transactions
 Information on investees
 Information on investment in Mainland China
 Major shareholders
(14) Segment information
Page

1
2
3
4
5
6
7
8
8
8~9
9~11
11
11~31
31~33
33
33
33
33
34
34~36
36
36
37
37~38

3

Independent Auditors’ Review Report

To the Board of Directors of RECTRON LTD. Company

Introduction

We have reviewed the accompanying consolidated balance sheets of the RECTRON LTD. Company and its subsidiaries as of March 31, 2024 and 2023, and the related consolidated statements of comprehensive income, changes in equity and cash flows for the three months ended March 31, 2024 and 2023, and notes to the consolidated financial statements, including a summary of significant accounting policies. Management is responsible for the preparation and fair presentation of the consolidated financial statements in accordance with the Regulations Governing the Preparation of Financial Reports by Securities Issuers and International Accounting Standard 34, “Interim Financial Reporting” endorsed and issued into effect by the Financial Supervisory Commission of the Republic of China. Our responsibility is to express a conclusion on the consolidated financial statements based on our reviews.

Scope of Review

Except as explained in the Basis for Qualified Conclusion paragraph, we conducted our reviews in accordance with the Standard on Review Engagements 2410, "Review of Financial Information Performed by the Independent Auditor of the Entity" of the Republic of China. A review of the consolidated financial statements consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with the Standards on Auditing of the Republic of China and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.

Basis for Qualified Conclusion

As stated in Note 4(b), the consolidated financial statements included the financial statements of certain non-significant subsidiaries, which were not reviewed by independent auditors. These financial statements reflect total assets amounting to $238,053 thousand and $242,773 thousand, constituting 10% and 11% of consolidated total assets as of March 31, 2024 and 2023, respectively, total liabilities amounting to $8,961 thousand and $21,135 thousand, constituting 1% and 5% of consolidated total liabilities as of March 31, 2024 and 2023, respectively, and total comprehensive income (loss) amounting to $2,229 thousand and $6,634 thousand, constituting 8% and 85% of consolidated total comprehensive income (loss) for the three months ended March 31, 2024 and 2023, respectively.

Qualified Conclusion

Except for the adjustments, if any, as might have been determined to be necessary had the financial statements of certain consolidated subsidiaries and equity accounted investee companies described in the Basis for Qualified Conclusion paragraph above been reviewed by independent auditors, based on our reviews, nothing has come to our attention that causes us to believe that the accompanying consolidated financial statements do not present fairly, in all material respects, the consolidated financial position of the RECTRON LTD. Company and its subsidiaries as of March 31, 2024 and 2023, and of its consolidated financial performance and its consolidated cash flows for the three months ended March 31, 2024 and 2023 in accordance with the Regulations Governing the Preparation of Financial Reports by Securities Issuers and International Accounting Standard 34, “Interim Financial Reporting” endorsed and issued into effect by the Financial Supervisory Commission of the Republic of China

3-1

Other Matters

We did not review the financial statements of certain consolidated subsidiaries, with total assets of $21,639 thousand and $26,020 thousand, representing 1% and 1% of the related consolidated total assets as of March 31, 2024 and 2023, and net sales of $707 thousand and $977 thousand, representing 0% and 1% of the related consolidated total net sales for the three months ended March 31, 2024 and 2023, respectively. Those financial statements were reviewed by other auditors whose reports have been furnished to us, and our review, insofar as it relates to the amounts included for certain consolidated subsidiaries, are based solely on the reports of the other auditors.

The engagement partners on the reviews resulting in this independent auditors’ review report are Shih-Chin Chih and Hsin-Ting Huang.

KPMG

Taipei, Taiwan (Republic of China) May 14, 2024

Notes to Readers

The accompanying consolidated financial statements are intended only to present the consolidated financial position, financial performance and its cash flows in accordance with the accounting principles and practices generally accepted in the Republic of China and not those of any other jurisdictions. The standards, procedures and practices to review such consolidated financial statements are those generally accepted and applied in the Republic of China.

The independent auditors’ review report and the accompanying consolidated financial statements are the English translation of the Chinese version prepared and used in the Republic of China. If there is any conflict between, or any difference in the interpretation of the English and Chinese language independent auditors’ review report and consolidated financial statements, the Chinese version shall prevail.

4

(English Translation of Consolidated Financial Statements Originally Issued in Chinese.) Reviewed only, not audited in accordance with Standards on Auditing as of March 31, 2024 and 2023 Rectron LTD. and Subsidiaries

Consolidated Balance Sheets

March 31, 2024, December 31 and March 31, 2023 (Expressed in Thousands of New Taiwan Dollar)

Assets
Current assets:
1100
Cash and cash equivalents (note 6(a))
1110
Current financial assets at fair value through
profit or loss (note 6(b))
1150
Trade notes receivable net (note 6(c) and (n))
1170
Trade receivables net (note 6(c), (n) and 7)
1200
Other receivables (note 7)
1220
Total current tax assets
130X
Inventories (note 6(d))
1410
Prepayments(note 7)
1479
Other current assets
Non-current assets:
1517 Non-current financial assets at fair value through
other comprehensive income (note 6(b))
1600 Property, plant and equipment (note 6(e), 8 and 9)
1755 Right-of-use assets (note 6(f), and 9)
1760 Investment property (note 6(g) , 7, 8 and 9)
1840 Deferred tax assets
1990 Other non-current assets (note 6(c) and 7)
Total assets
March 31, 2024
Amount
%
$ 579,185
24
15,452
1
467
-
111,314
5
18,338
1
-
-
132,144
5
9,207
-
2,983
-
869,090
36
59,273
3
455,806
19
15,574
1
962,707
41
-
-
3,225
-
1,496,585
64
2,365,675
100
December 31, 2023 December 31, 2023 March 31, 2023
Amount
%
303,505 14
23,457 1
3,642
-
120,409
6
1,922
-
1,683
-
121,835
6
20,356
1
2,448
-
599,257
28
55,184
3
487,868 23
14,919
1
972,811 45
1,321
-
7,101
-
1,539,204 72
2,138,461
100
Liabilities and Equity
Current liabilities:
2100
Short-term borrowings (note 6(h))
2130
Current contract liabilities (note 6(n))
2170
Trade payables
2200
Other payables (note 7 )
2230
Current tax liabilities
2280
Current lease liabilities (note 7 )
2300
Other current liabilities
Non-current liabilities
2580
Non-current lease liabilities (note 7 )
2640
Net defined benefit liability, non-current
2570
Deferred tax liabilities
2600
Other non-current liabilities (note 7 )
Total liabilities
Equity (notes 6(l)):
3110
Ordinary shares
3200
Capital surplus
3310
Legal reserve
3320
Special reserve
3351
Retained earnings
3400
Other equity
Total equity
Total liabilities and equity
March 31, 2024

Amount
%
$ 10,000
-
32
-
79,181
3
77,361
3
11,108
-
2,157
-
359,147
16
538,986
22
5,101
-
1,831
-
62,684
3
4,756
-
74,372
3
613,358
25
1,663,029
70
9
-
51,988
2
60,074
3
54,347
2
(77,130)
(2)
1,752,317
75
$ 2,365,675
100
March 31, 2024

Amount
%
$ 10,000
-
32
-
79,181
3
77,361
3
11,108
-
2,157
-
359,147
16
538,986
22
5,101
-
1,831
-
62,684
3
4,756
-
74,372
3
613,358
25
1,663,029
70
9
-
51,988
2
60,074
3
54,347
2
(77,130)
(2)
1,752,317
75
$ 2,365,675
100
December 31, 2023
Amount
%
15,000
1
68
-
75,697
3
32,533
1
6,915
-
4,419
-
351,322
15
485,954
20
3,102
-
2,209
-
62,684
3
4,756
-
72,751
3
558,705
23
1,663,029
71
9
-
51,988
2
60,074
3
87,640
4
(87,143)
(3)
1,775,597
77
2,334,302
100
March 31, 2023


$
Amount
$ 579,185
15,452
467
111,314
18,338
-
132,144
9,207
2,983
869,090
59,273
455,806
15,574
962,707
-
3,225
1,496,585
2,365,675
Amount
%
561,703
24
34,517
1
417
-
90,374
4
1,622
-
307
-
135,578
6
6,883
-
3,261
-
834,662
35
57,636
2
458,587
20
15,759
1
963,889
42
-
-
3,769
-
1,499,640
65
2,334,302
100
Amount

$ 10,000
32
79,181
77,361
11,108
2,157
359,147
538,986
5,101
1,831
62,684
4,756
74,372
613,358
1,663,029
9
51,988
60,074
54,347
(77,130)
1,752,317
$ 2,365,675






Amount
%
30,000
1
3,971
-
109,541
5
161,671
8
28,284
1
2,357
-
1,375
-
337,199
15
3,869
-
3,130
-
62,679
3
7,763
-
77,441
3
414,640
18
1,663,029 78
9
-
34,364
2
34,924
2
54,343
3
(62,848)
(3)
1,723,821
82
2,138,461
100







$


See accompanying notes to financial statements.

5

(English Translation of Consolidated Financial Statements Originally Issued in Chinese.)

Reviewed only, not audited in accordance with Standards on Auditing Rectron LTD. and Subsidiaries

Consolidated Statement of Comprehensive Income

For the three months ended March 31, 2024 and 2023 (Expressed in Thousands of New Taiwan Dollar, except for Earnings per Common Share)

For the three months ended March 31

4000
Operating revenue(notes 6(n) and 7)
$ 5000
Operating costs (notes 6(d) and 6(j))
Gross profit from operations
Operating expenses (notes 6(c)6(j)6(o) and 12):
6100
Selling expenses
6200
Administrative expenses
6300
Research and development expenses
Total operating expenses
Net operating income
Non-operating income and expenses(notes 6(p) and 7):
7010
Other income
7020
Other gains and losses
7050
Finance costs
7950
Total non-operating income and expenses
Profit before tax
Total tax expense (note 6(k))
Profit
8300
Other comprehensive income (loss):
8310
Components of other comprehensive income that will not be reclassified to profit or loss:
8316
Unrealized gains (losses) from investments in equity instruments measured at fair value
through other comprehensive income
8349
Income tax related to components of other comprehensive income that will not be
reclassified to profit or loss
Components of other comprehensive income that will not be reclassified to profit or loss
8360
Components of other comprehensive income (loss) that will be reclassified to profit or
loss:
Components of other comprehensive income that will be reclassified to profit or loss:
8361
Exchange differences on translation
8367
Unrealized gains (losses) from investments in debt instruments measured at fair value
through other comprehensive income
8399
Income tax related to components of other comprehensive income that will be reclassified to
profit or loss (note 6(p))
Total components of other comprehensive income that will be reclassified to
profit or loss
8300
Other comprehensive income, net
8500
Comprehensive income
$
Profit, attributable to:
8610
Profit, attributable to owners of parent
$
Comprehensive income attributable to:
8710
Comprehensive income, attributable to owners of parent
$
Earnings per common share (expressed in dollars) (note 6(m))
9750
Basic earnings per share
$
9810
Diluted earnings per share
$




2024
%

147,257
100
92,137
63
55,120
37
9,756
7
33,550
23
1,531
1
44,837
31
10,283
6
2,819
2
9,808
7
(84)
-
12,543
9
22,826 15
4,565
3
18,261
12
1,046
1
-
-
1,046
1
10,105
7
(1,138)
(1)
-
-
8,967
6
10,013
7
28,274
19
18,261
12
28,274
19
0.11

0.11
2023
%
167,675
100
113,476
68
54,199
32
10,514
6
35,508
21
2,017
1
48,039
28
6,160
4
601
-
6,473
4
(164)
-
6,910
4
13,070
8
2,473
1
10,597
7
15
-
-
-
15
-
(4,176)
(2)
1,387
1
-
-
(2,789)
(1)
(2,774)
(1)
7,823
6
10,597
7
7,823
6
0.06
0.06
%
100
68
32
6
21
1
28
4
-
4
-
4
8
1
7
-
-
-

See accompanying notes to financial statements.

6

(English Translation of Consolidated Financial Statements Originally Issued in Chinese.)

Reviewed only, not audited in accordance with Standards on Auditing Rectron LTD. and Subsidiaries

Consolidated Statement of Changes in Equity

For the three months ended March 31, 2024 and 2023 (Expressed in Thousands of New Taiwan Dollar)

Balance at January 1, 2023
Net income
Other comprehensive income
Total comprehensive income
Appropriation and distribution of retained earnings:
Cash dividends of ordinary share
Balance at March 31, 2023
Balance at January 1, 2024
Net income
Other comprehensive income
Total comprehensive income
Appropriation and distribution of retained earnings:
Cash dividends of ordinary share
Balance at March 31, 2024
Attributable to owners ofparent Attributable to owners ofparent Attributable to owners ofparent Attributable to owners ofparent Attributable to owners ofparent Attributable to owners ofparent Attributable to owners ofparent Attributable to owners ofparent Attributable to owners ofparent Total Total equity Total equity
Ordinary
share
Capital surplus Retained earnings Total Other equity
Legal reserve Special reserve Exchange differences on
translation of foreign
financial
statements
Unrealized gains (losses)
from financial assets
measured at fair value
through other
comprehensive income
(55,153)
(4,921)

-
-
(4,176)
1,402

(4,176)
1,402

-
-

(59,329)
(3,519)

(83,104)
(4,039)

-
-
10,105
(92)

10,105
(92)

-

-

(72,999)
(4,131)
$1,663,029
-

-

-

-
$ 1,663,029
$ 1,663,029
-

-

-

-
$ 1,663,029




9
-
-
-
-
9
9
-
-
-
-
9




34,364
-
-
-
-
34,364
51,988
-
-
-
-
51,988




34,924
-
-
-
-
34,924
60,074
-
-
-
-
60,074




176,788
10,597
-
10,597
(133,042)
54,343
87,640
18,261
-
18,261
(51,554)
54,347




(55,153)
-
(4,176)
(4,176)
-
(59,329)
(83,104)
-
10,105
10,105
-
(72,999)




(60,074)
-
(2,774)
(2,774)
-
(62,848)
(87,143)
-
10,013
10,013
-
(77,130)





1,849,040
10,597
(2,774)
7,823
(133,042)
1,723,821
1,775,597
18,261
10,013
28,274
(51,554)
1,752,317










$
































See accompanying notes to financial statements.

7

(English Translation of Consolidated Financial Statements Originally Issued in Chinese.)

Reviewed only, not audited in accordance with Standards on Auditing

Rectron LTD. and Subsidiaries

Consolidated Statement of Cash Flows

For the three months ended March 31, 2024 and 2023 (Expressed in Thousands of New Taiwan Dollars)

Cash flows from (used in) operating activities:
Profit before tax
Adjustments:
Adjustments to reconcile profit (loss):
Depreciation expenses
Amortization expenses
Expected credit losses (gains)
Interest expenses
Interest income
Dividend income
Net losses (gains) on financial assets at fair value through profit or loss
Foreign exchange loss (gain) on financial assets
Property, plant and equipment transferred to expenses
Total adjustments to reconcile profit
Changes in operating assets and liabilities:
Changes in operating assets:
Notes receivable
Trade receivables
Other receivables
Inventories
Prepayments
Other current assets
Total changes in operating assets
Changes in operating liabilities:
Current contract liabilities
Trade payables
Other payables
Other current liabilities
Net defined benefit liability
Total changes in operating liabilities
Total changes in operating assets and liabilities
Total adjustments
Cash inflow generated from operations
Interest received
Dividends received
Interest paid
Income taxes paid
Income taxes received
Net cash flows from operating activities
Cash flows from (used in) investing activities:
Acquisition of financial assets at fair value through profit or loss
Proceeds from disposal of financial assets at fair value through profit or loss
Acquisition of property, plant and equipment
Increase in other non-current assets
Net cash flows used in investing activities
Cash flows from (used in) financing activities:
Increase in short-term borrowings
Decrease in short-term borrowings
Increase in guarantee deposits received
Repayment of lease principal
Net cash flows used in financing activities
Effect of exchange rate changes on cash and cash equivalents
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents at the beginning of period
Cash and cash equivalents at the end of period
For For the three months ended March 31, the three months ended March 31, the three months ended March 31, the three months ended March 31,
2024 2023







$ 22,826
12,211
760
(737)
84
(2,755)
(64)
(5,234)
(1,296)
1,315

4,284

(50)
(20,203)
(130)
3,434
(2,324)
278

(18,995)

(36)
3,484
(6,705)
7,825
(378)

4,190

(14,805)

(10,521)
12,305
2,779
64
(105)
(65)
-

14,978

(9,089)
16,826
(4,672)
(216)

2,849

10,000
(15,000)
-
(551)

(5,551)

5,206
17,482
561,703


579,185
13,070
13,153
982
(491)
164
(568)
(33)
(7,378)
830
-
6,659
















$
(1,559)
36,459
1,072
19,869
2,084
1,254
59,179
2,030
(19,997)
(7,437)
109
(379)
(25,674)
33,505
40,164

53,234
384
33
(161)
-
14
53,504
(7,348)
16,926
(645)
(844)
8,089
1,000
(1,000)
387
(840)
(453)
(3,597)
57,543
245,962
303,505

See accompanying notes to financial statements.

8

(English Translation of Consolidated Financial Statements Originally Issued in Chinese.)

REVIEWED ONLY, NOT AUDITED IN ACCORDANCE WITH THE Standards on Auditing AS OF MARCH 31, 2024 AND 2023

Rectron Ltd. and Subsidiaries

Notes to Consolidated Financial Statements

March 31, 2024 and 2023

(Expressed in Thousands of New Taiwan Dollar, except for Earnings per Share Information and Unless Otherwise Specified)

1. Company history

Rectron Ltd. (the “Company”) was established and approved by the Ministry of Economic Affairs on January 23, 1976. The registered address is No. 71, Zhongshan Road, Tucheng District, New Taipei City. The Company was originally named "Rectron Precision Electronics Industry Co., Ltd." and changed its name to "Rectron Ltd." on June 29, 2000, as resolved by the shareholders' meeting and approved by the Ministry of Economic Affairs.

The Company and its subsidiaries (together referred to as the “Group”) main business operations include the manufacture and sale of various rectifiers, other semiconductor components, rental and sale of real estate, trading of wines, and manufacture and sale of medical equipment.

2. Approval date and procedures of the consolidated financial statements

The consolidated financial statements for the three months ended March 31, 2024 and 2023 were authorized for issuance by the board of directors on May 14, 2024.

3. New standards and interpretations not yet adopted

  • (a) The impact of the International Financial Reporting Standards (“IFRSs”) endorsed by the Financial Supervisory Commission, R.O.C. which have already been adopted.

The Group has initially adopted the (following) new amendments, which do not have a significant impact on its consolidated financial statements, from January 1, 2024

  • Amendments to IAS 1 “Classification of Liabilities as Current or Non-current”

  • Amendments to IAS 1 “Non-current Liabilities with Covenants”

  • Amendments to IAS 7 and IFRS 7 “Supplier Finance Arrangements”

  • Amendments to IFRS 16 “Lease Liability in a Sale and Leaseback”

(b) The impact of IFRS issued by IASB but not yet endorsed by the FSC

The following new and amended standards, which may be relevant to the Group, have been issued by

the International Accounting Standards Board (IASB), but have yet to be endorsed by the FSC:

(Continued)

9

9
Standards
or
Interpretations
IFRS 18
“Presentation
and Disclosure
in Financial
Statements”
Content of amendment
Effective date
per IASB
The new standard introduces three categories of income and
expenses, two income statement subtotals and one single
note on management performance measures. The three
amendments, combined with enhanced guidance on how to
disaggregate information, set the stage for better and more
consistent information for users, and will affect all the
entities.

A more structured income statement: under current
standards, companies use different formats to present
their results, making it difficult for investors to
compare financial performance across companies. The
new standard promotes a more structured income
statement, introducing a newly defined ‘operating
profit’ subtotal and a requirement for all income and
expenses to be allocated between three new distinct
categories based on a company’s main business
activities.

Management performance measures (MPMs): the new
standard introduces a definition for management
performance measures, and requires companies to
explain in a single note to the financial statements
why the measure provides useful information, how it
is calculated and reconcile it to an amount determined
under IFRS Accounting Standards.

Greater disaggregation of information: the new
standard includes enhanced guidance on how
companies group information in the financial
statements. This includes guidance on whether
information is included in the primary financial
statements or is further disaggregated in the notes.
January 1, 2027

The Group is evaluating the impact on its consolidated financial position and consolidated financial performance upon the initial adoption of the abovementioned standards or interpretations. The results thereof will be disclosed when the Group completes its evaluation.

The Group does not expect the following other new and amended standards, which have yet to be endorsed by the FSC, to have a significant impact on its consolidated financial statements:

  • Amendments to IFRS 10 and IAS 28 “Sale or Contribution of Assets Between an Investor and Its Associate or Joint Venture”

  • IFRS 17 “Insurance Contracts” and amendments to IFRS 17 “ Insurance Contracts”

  • Amendments to IAS21“Lack of Exchangeability”

4. Summary of significant accounting policies

(1) Statement of compliance

These consolidated financial statements have been prepared in accordance with the preparation and guidelines of IAS 34 “Interim Financial Reporting” which are endorsed and issued into effect by FSC, and do not include all of the information required by the Regulations and International

(Continued)

10

Financial Reporting Standards, International Accounting Standards, IFRIC Interpretations and SIC Interpretations endorsed and issued into effect by the FSC (hereinafter referred to IFRS endorsed by the FSC) for a complete set of the annual consolidated financial statements.

Except the following accounting policies mentioned below, the significant accounting policies adopted in the consolidated financial statements are the same as those in the consolidated financial statement for the year ended December 31, 2023. For the related information, please refer to note 4 of the consolidated financial statements for the year ended December 31, 2023.

  • (2) Basis of consolidation

  • (a) List of subsidiaries in the consolidated financial statements:

Name of
Name of
investor
subsidiary
Principal activity
The
Company
Rectron
(China)
Limited
(Rectron
China)
Sales of rectifiers, etc.
Electronic components
The
Company
RECTRON
ELECTRONIC
ENTERPRISE
S,INC (REEI)
Sales of rectifiers, etc.
Electronic components
The
Company
CHU-TING
ENTERPRISE
CO., LTD.
(Chu-Ting)
Wholesale of tobacco and
alcohol products and
manufacturing and sales of
medical equipment.
Rectron
(China)
Limited
Zhejiang
Rectron
Electronic
Co.,LTD.
(Zhejiang
Rectron)
Manufacturing and sales of
rectifiers and other
electronic components.
Shareholding
March 31,
2024
December
31, 2023
March 31,
2023
Description
100%
100%
100%
Subsidiaries with direct
ownership of voting rights
exceeding 50% of the
total shares issued.
100%
100%
100%
Subsidiaries with direct
ownership of voting rights
exceeding 50% of the
total shares issued.(Note)
100%
100%
100%
Subsidiaries with direct
ownership of voting rights
exceeding 50% of the
total shares issued. (Note)

100%
100%
100%
Subsidiaries with indirect
ownership of voting rights
exceeding 50% of the
total shares issued.

Note : It is an insignificant subsidiary that the financial statements have not been reviewed.

  • (b) List of subsidiaries which are not included in the consolidated financial statements: None.

  • (3) Classification of current and non-current assets and liabilities

An asset is classified as current under one of the following criteria, and all other assets are classified as non current.

  1. It is expected to be realized, or intended to be sold or consumed, in the normal operating cycle;

  2. It is held primarily for the purpose of trading;

  3. It is expected to be realized within twelve months after the reporting period; or

  4. The asset is cash or cash equivalents (as defined in IAS 7), except when there are other restrictions that would prevent the asset from being exchanged or used to settle a liability for at least twelve months after the reporting period.

A liability is classified as current under one of the following criteria, and all other liabilities are classified as non current.

An entity shall classify a liability as current when:

  1. It is expected to be settled in the normal operating cycle;

  2. It is held primarily for the purpose of trading;

  3. It is due to be settled within twelve months after the reporting period; or

  4. As of the end of the reporting period, there is no right to defer the settlement of the liability for at least twelve months after the reporting period.

(Continued)

11

(4) Employee benefits

The pension cost in the interim period was calculated and disclosed on a year-to-date basis by using the actuarially determined pension cost rate at the end of the prior fiscal year.

(5) Income taxes

The income tax expenses have been prepared and disclosed in accordance with paragraph B12 of International Financial Reporting Standards 34, Interim Reporting.

Income tax expenses for the period are best estimated by multiplying pre-tax income for the interim reporting period using the effective annual tax rate as forecasted by the management. This should be recognized fully as tax expense for the current period (and allocated to current and deferred taxes based on its proportionate size).

For a change in tax rate that is substantively enacted in an interim period, the effect of the change should immediately be recognized in the interim period in which the change occurs.

Temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and their respective tax bases shall be measured based on the tax rates that have been enacted or substantively enacted at the time of the asset or liability is recovered or settled, and be recognized directly in equity or other comprehensive income as tax expense.

5. Significant accounting assumptions and judgments, and major sources of estimation uncertainty

The preparation of the consolidated financial statements in conformity with the Regulations and IFRSs (in accordance with IAS 34 “Interim Financial Reporting” and endorsed by the FSC) requires management to make judgments, estimates and assumptions that affect the application of the accounting policies and the reported amount of assets, liabilities, income and expenses. Actual results may differ from these estimates.

Except for the following, the preparation of the consolidated interim financial statements, estimates and underlying assumptions are reviewed on an ongoing basis which are in conformity with the consolidated financial statements for the year ended December 31, 2023. For related information, please refer to note 5 of the consolidated financial statements for the year ended December 31, 2023.

6. Explanation of significant accounts

Except for the following disclosures, there were no material differences in the disclosures of significant accounts between the interim consolidated financial statements for the current period and the 2023 consolidated financial statements. Please refer to note 6 to the 2023 annual consolidated financial statements.

  • (a) Cash and cash equivalents
Cash on hand and petty cash
Cash in banks
Time deposits
Cash and cash equivalents in the consolidated
statement of cash flows
March 31,
2024
December
31, 2023
March 31,
2023
$ 271
553,314
25,600
295

533,774

27,634
239
272,816
30,450
$ 579,185
561,703
303,505

(Continued)

12

Please refer to Note 6(q) for the fair value sensitivity analysis and interest rate risk of the financial assets and liabilities.

(b) Financial assets

  1. Current financial assets at fair value through profit or loss
March 31, 2024
December 31, 2023
March 31, 2023
Financial assets
designation as measured at fair
value through profit or loss
Shares of stock of overseas
listed companies - RTX
$ -
15,504
-
Shares of stock of overseas
listed companies - OXY
-
14,670
7,852
Shares of stock of overseas
listed companies - LMT
14,617
-
-
Shares of stock of overseas
listed companies - Tesla
-
-
8,612
Shares of stock of listed
companies -TSMC
-
3,558
6,396
Assets mandatorily measured at
fair value through profit or loss:
Beneficiary certificates
835
785
597
Total
$ 15,452
34,517
23,457
2. Non-current financial assets at fair value through other comprehensive income
March 31, 2024
December 31, 2023
March 31, 2023
Debt investments at fair value
through other comprehensive
income
Corporate bonds – Apple
$ 25,846
25,735
25,945
Corporate bonds – AT&T
9,426
9,144
8,983
Corporate bonds – Pfizer
4,157
4,121
4,241
Corporate bonds – SocGen
3,252
3,090
-
Equity investments at fair value
through other comprehensive
income
Shares of stock of unlisted
companies
16,592
15,546
16,015
Total
$ 59,273
57,636
55,184
March 31, 2024
December 31, 2023
March 31, 2023
Financial assets
designation as measured at fair
value through profit or loss
Shares of stock of overseas
listed companies - RTX
$ -
15,504
-
Shares of stock of overseas
listed companies - OXY
-
14,670
7,852
Shares of stock of overseas
listed companies - LMT
14,617
-
-
Shares of stock of overseas
listed companies - Tesla
-
-
8,612
Shares of stock of listed
companies -TSMC
-
3,558
6,396
Assets mandatorily measured at
fair value through profit or loss:
Beneficiary certificates
835
785
597
Total
$ 15,452
34,517
23,457
2. Non-current financial assets at fair value through other comprehensive income
March 31, 2024
December 31, 2023
March 31, 2023
Debt investments at fair value
through other comprehensive
income
Corporate bonds – Apple
$ 25,846
25,735
25,945
Corporate bonds – AT&T
9,426
9,144
8,983
Corporate bonds – Pfizer
4,157
4,121
4,241
Corporate bonds – SocGen
3,252
3,090
-
Equity investments at fair value
through other comprehensive
income
Shares of stock of unlisted
companies
16,592
15,546
16,015
Total
$ 59,273
57,636
55,184
March 31, 2024
December 31, 2023
March 31, 2023
Financial assets
designation as measured at fair
value through profit or loss
Shares of stock of overseas
listed companies - RTX
$ -
15,504
-
Shares of stock of overseas
listed companies - OXY
-
14,670
7,852
Shares of stock of overseas
listed companies - LMT
14,617
-
-
Shares of stock of overseas
listed companies - Tesla
-
-
8,612
Shares of stock of listed
companies -TSMC
-
3,558
6,396
Assets mandatorily measured at
fair value through profit or loss:
Beneficiary certificates
835
785
597
Total
$ 15,452
34,517
23,457
2. Non-current financial assets at fair value through other comprehensive income
March 31, 2024
December 31, 2023
March 31, 2023
Debt investments at fair value
through other comprehensive
income
Corporate bonds – Apple
$ 25,846
25,735
25,945
Corporate bonds – AT&T
9,426
9,144
8,983
Corporate bonds – Pfizer
4,157
4,121
4,241
Corporate bonds – SocGen
3,252
3,090
-
Equity investments at fair value
through other comprehensive
income
Shares of stock of unlisted
companies
16,592
15,546
16,015
Total
$ 59,273
57,636
55,184
March 31, 2024
December 31, 2023
March 31, 2023
Financial assets
designation as measured at fair
value through profit or loss
Shares of stock of overseas
listed companies - RTX
$ -
15,504
-
Shares of stock of overseas
listed companies - OXY
-
14,670
7,852
Shares of stock of overseas
listed companies - LMT
14,617
-
-
Shares of stock of overseas
listed companies - Tesla
-
-
8,612
Shares of stock of listed
companies -TSMC
-
3,558
6,396
Assets mandatorily measured at
fair value through profit or loss:
Beneficiary certificates
835
785
597
Total
$ 15,452
34,517
23,457
2. Non-current financial assets at fair value through other comprehensive income
March 31, 2024
December 31, 2023
March 31, 2023
Debt investments at fair value
through other comprehensive
income
Corporate bonds – Apple
$ 25,846
25,735
25,945
Corporate bonds – AT&T
9,426
9,144
8,983
Corporate bonds – Pfizer
4,157
4,121
4,241
Corporate bonds – SocGen
3,252
3,090
-
Equity investments at fair value
through other comprehensive
income
Shares of stock of unlisted
companies
16,592
15,546
16,015
Total
$ 59,273
57,636
55,184





55,184

(Continued)

13

  • (1) Debt investments at fair value through other comprehensive income

The Company consolidated investments in bonds measured at fair value through other comprehensive income in the financial statements as of March 31, 2024 December 31, 2023 and March 31, 2023. The effective interest rates range respectively from 2.00% to 4.90%, 2.00% to 4.90%, and 2.00% to 4.01%, and the maturity dates range from 2036 to 2045. The Company holds bond investments through the business model of collecting contractual cash flows and selling financial assets, and therefore reports them as financial assets measured at fair value through other comprehensive income.

  • (2) Equity investments at fair value through other comprehensive income

The Group designated the investments shown above as equity securities at fair value through other comprehensive income because these equity securities represent those investments that the Group intends to hold for the long term for strategic purposes.

  • (3) For credit risk (including the impairment of debt investments) and market risk; please refer to note 6(q).

  • (4) As of March 31, 2024, December 31, 2023 and March 31, 2023, the Group’s financial assets were not pledged as collateral.

(c) Trade receivables and notes receivable

March 31, 2024
Notes receivable from operating
activities
$ 467
Trade receivables
135,914
Trade receivables–Non-current
48,227
Less: Loss allowance
(72,827)
$
111,781
December 31, 2023
417
114,752
48,227
(72,605)
90,791
March 31, 2023
3,642
148,392
48,227
(76,210)
124,051
March 31, 2023
3,642
148,392
48,227
(76,210)
124,051

The Group applies the simplified approach to provide for its expected credit losses, i.e. the use of lifetime expected loss provision for all receivables. To measure the expected credit losses, trade receivables have been grouped based on shared credit risk characteristics and the days past due, as well as incorporated forward looking information, including macroeconomic and relevant industry information. The loss allowance provision were determined as follows:

(Continued)

14

Current
Within 180 days past
due.
More than 180 days
past due

Current
Within 180 days past
due.
More than 180 days
past due
Current
Within 180 days past
due.

More than 180 days
past due
March 31, 2024
Gross carrying
amount
$ 94,880
17,022
72,706
$ 184,608
Weighted-
average loss rate
0.05%~1.88%
0.05%~9.13%
0%~100%

December 31, 2023
Loss allowance
provision
32
103
72,692
72,827
Gross carrying
amount
$ 66,501
24,424
72,471
$ 163,396
Weighted-
average loss rate
0.05%~1.84%
0.05%~8.89%
100%

March 31, 2023
Loss allowance
provision
19
129
72,457
72,605
Gross carrying
amount
$ 104,483
19,886
75,892
$ 200,261
Weighted-
average loss rate
0.05%~1.61%
3.99%~7.42%
0%~100%
Loss allowance
provision
35
297
75,878
76,210

The movements in the allowance for trade receivables and notes receivable were as follows:

Balance at January 1
Impairment losses recognized
Impairment losses reversed
Amounts written off
Foreign exchange gains/(losses)
Balance at March 31
For the three months ended
March 31,
For the three months ended
March 31,
For the three months ended
March 31,
For the three months ended
March 31,
2024
72,605
11
(748)
-
959
72,827
2023
78,794
50
(541)
(1,637)
(456)
76,210
$
$

(Continued)

15

As of March 31, 2024, December 31, 2023 and March 31, 2023, the Group’s the aforementioned trade receivables and notes receivable were not pledged as collateral.

  • (d) Inventories
entories
March 31,
2024
Raw materials and consumables
25,638
Work in progress
19,313
Finished goods
72,785
Merchandise
27,474
Goods and materials in transit
4,116
Subtotal
149,326
Less: Allowance for inventory market decline
and obsolescence
(17,182)
132,144
March 31,
2024
December 31,
2023
March 31,
2023
25,638
19,313
72,785
27,474
4,116
149,326

24,914

19,707

76,590

28,176

2,614

152,001

31,519

26,408

54,483

27,435
336

140,181

(16,423)
(18,346)
132,144
**135,578 **

121,835

As of March 31, 2024, January 1to 2023 and March 31, 2023, the details of the cost of sales were as follows:

Inventory that has been sold
Write-down of inventories (Reversal of write-downs)
The impact of actual production capacity being lower
than normal capacity.
For the three months ended March 31, For the three months ended March 31, For the three months ended March 31,
2024
85,873
759
3,722
2023
$ $ 107,965
2,003
523
110,491

90,354

As of March 31, 2024, December 31, 2023 and March 31, 2023, the Group’s the aforementioned trade receivables and notes receivable were not pledged as collateral.

(Continued)

16

(e) Property, plant and equipment

The cost and accumulated depreciation of the property, plant and equipment of the Group for the three months ended March 31, 2024 and 2023 were as follows:

Cost:
Balance at January 1, 2024
Additions
Reclassification
Effect of movement in exchange rates
Balance at March 31, 2024
Balance at January 1, 2023
Additions
Effect of movement in exchange rates
Balance at March 31, 2023
Accumulated depreciation:
Balance at January 1, 2024
Depreciation
Effect of movement in exchange rates
Balance as of March 31, 2024
Balance as of January 1, 2023
Depreciation
Effect of movement in exchange rates
Balance at March 31, 2023
Carrying value:
Balance at January 1, 2024
Balance at March 31, 2024
Balance at January 1, 2023
Balance at March 31, 2023
Land

181,394
-
-
181,394

181,394
-
-
181,394

-
-
-
-

-
-
-
-
181,394
181,394
181,394
181,394
Buildings and
structures
248,881
-
3,478
252,359
253,393
-
(869)
252,524
135,743
2,529
2,089
140,361
128,104
2,604
(482)
130,226
113,138
111,998
125,289
122,298
Machinery and
equipment
677,096
1,318
9,178
687,592
686,790
-
(2,389)
684,401
531,955
5,858
7,778
545,591
518,023
6,182
(1,924)
522,281
145,141
142,001
168,767
162,120
Office
equipment
56,394
887
1,806
424
59,511
56,420
124
(102)

56,442
50,817
669
372
51,858
47,985
934
(90)
48,829
5,577
7,653
8,435
7,613
C onstruction in
progress
13,337
2,467
(3,121)
77
12,760
13,952
521
(30)
14,443
-
-
-
-
-
-
-
-
13,337
12,760
13,952
14,443
Total
$ $
$ $
$ $
$ $
$
$
$
$
1,177,102
4,672
(1,315)
13,157
1,193,616

1,191,949
645
(3,390)
1,189,204
718,515
9,056
10,239
737,810
694,112
9,720
(2,496)
701,336
458,587
455,806
497,837
487,868

As of March 31, 2024, December 31, 2023 and March 31, 2023, the Property, plant and equipment of the Group had been pledged as collateral for long-term borrowings; please refer to note 8.

For the details regarding the subsidiary Zhejiang Rectron housing and construction relocation agreement with Jiashan Economic Development Zone Asset Management Co., Ltd., please refer to Note 9(b).

(f) Right-of-use assets

The Group leases many assets including land and buildings, vehicles, and other equipment. Information about leases for which the Group is a lessee is presented below:

Cost:
Balance at January 1, 2024
Effect of movement in exchange rates
Balance at March 31, 2024
Land
$ 9,906
224
$ 10,130
Buildings

12,826
533
13,359
Machinery and
equipment

-

-

-
Other
equipment

343
-

343
Total

23,075

757

23,832

(Continued)

17

Balance at January 1, 2023
Additions
Effect of movement in exchange rates
Balance at March 31, 2023
Accumulated
depreciation
and impairment losses:
Balance at January 1, 2024
Depreciation for the year
Effect of movement in exchange rates
Balance at March 31, 2024
Balance at January 1, 2023
Depreciation for the year
Effect of movement in exchange rates
Balance at March 31, 2023
Carrying amount:
Balance at January 1, 2024
Balance at March 31, 2024
Balance at January 1, 2023
Balance at March 31, 2023
Land
$ 10,196
(56)
$ 10,140
$ 1,520
77
35
$ 1,632
$ 1,252
78
(7)
$ 1,323
$ 8,386
$ 8,498
$ 8,944
$ 8,817
Buildings

12,827
(131)
12,696
5,724
561
251
6,536
6,408
701
(69)
7,040
7,102
6,823
6,419
5,656
Machinery and
equipment

1,442
-

1,442

-

-

-


1,202

120
-

1,322
-
-
240
120
Machinery and
equipment

1,442
-

1,442

-

-

-


1,202

120
-

1,322
-
-
240
120
Other
equipment

-
343
-

343

72

18
-
90


17
-

17
271
253
-
326
Other
equipment

-
343
-

343

72

18
-
90


17
-

17
271
253
-
326
Other
equipment

-
343
-

343

72

18
-
90


17
-

17
271
253
-
326
Other
equipment

-
343
-

343

72

18
-
90


17
-

17
271
253
-
326
Total

24,465
343
(187)
24,621






7,316
656
286
8,258



8,862
916
(76)
9,702




15,759
15,574
15,603
14,919

For the details regarding the subsidiary Zhejiang Rectron right-of-use assets land relocation agreement with Jiashan Economic Development Zone Asset Management Co., Ltd., please refer to Note 9(b).

(g) Investment property

Cost:
Balance at January 1, 2024
Effect of movement in exchange rates
Balance at March 31, 2024
Balance at January 1, 2023
Effect of movement in exchange rates
Balance at March 31, 2023
Land and
improvements
$ 663,510
-
$ 663,510
$ 663,510
-
$ 663,510
Buildings
373,879
1,891
375,770
376,331
(472)
375,859
Total

1,037,389

1,891

1,039,280

1,039,841
(472)

1,039,369

(Continued)

18

Accumulated depreciation and
impairment losses:
Balance at January 1, 2024
Depreciation for the year
Effect of movement in exchange rates
Balance at March 31, 2024
Balance at January 1, 2023
Depreciation for the year
Effect of movement in exchange rates
Balance at March 31, 2023
Carrying amount:
Balance at January 1, 2024
Balance at March 31, 2024
Balance at January 1, 2023
Balance at March 31, 2023
Land and
improvements
$ -
-
-
$ -
$ -
-
-
$ -
$ 663,510

$ 663,510

$ 663,510

$ 663,510
Buildings
73,500
2,499
574
76,573
64,163
2,517
(122)
66,558
300,379

299,197

312,168

309,301
Total

73,500

2,499

574

76,573

64,163

2,517
(122)

66,558
963,889

962,707

975,678

972,811
  1. Investment properties are self-owned assets held by the Consolidated Companies. The lease term for investment properties ranges from 1 to 6 years, and it is non-cancellable. Due to the need for organic renewal and industrial transformation and upgrading in the Jiashan Economic and Technological Development Industrial Park, where the subsidiary Zhejiang Rectron is located, Zhejiang Rectron agreed to vacate the premises with Jiashan Economic Development Zone Asset Management Co., Ltd. on September 22, 2023. Therefore, the lease contract was terminated at the end of August 2023. Please refer to Note 9(b) for details.

  2. Due to the restriction in the law at that time, private entities were not allowed to acquire agricultural land. Therefore, the Consolidated Companies appointed Mr. Lin Wen-Teng, one of the directors, to register the real estate investment under his personal name. To ensure the preservation of the Consolidated Companies' assets, the property has been pledged back to the Consolidated Companies.

  3. The fair value of investment property was not significantly different from those disclosed in Note 6(g) of the annual consolidated financial statements for the year ended December 31, 2023.

  4. As of March 31, 2024, December 31, 2023 and March 31, 2023, the Property, plant and equipment of the Group had been pledged as collateral for long-term borrowings; please refer to note 8.

(h) Short-term borrowings

Secured bank loans
Unused short-term credit lines
Range of interest rates
March 31, 2024
December 31, 2023
March 31, 2023
$ 10,000 15,000 30,000
$ 390,000 385,000 290,000
1.90%~2.01% 1.89%~2.20% 1.79%~1.89%

For the collateral for short-term borrowings, please refer to note 8.

(Continued)

19

(i)Operating Lease

There were no significant changes in operating lease for the three months ended March 31, 2024 and 2023. Please refer to Note 6(i) of the consolidated financial statements for the year ended December 31, 2023 for other related information.

(j)Provisions

1. Defined benefit plans

Management believes that there was no material volatility of the market, no material reimbursement and settlement or no other material onetime events since prior fiscal year. As a result, the pension cost in the accompanying interim period was measured and disclosed according to the actuarial report as of December 31, 2023 and 2022.

The expenses recognized in profit or loss for the Group are as follows:

Operating cost
Selling expenses
Administration expenses
Total
For the Three Months Ended March31 For the Three Months Ended March31
2024
$ 2
5
$ 7
2023
4
1
7
12
  1. Defined contribution plans

The Group’s employee benefits retirement expenses respectively.

Operating cost
Selling expenses
Administration expenses
Research and development expenses
Total
For the Three Months Ended March31 For the Three Months Ended March31
2024
$ 134
45
195
11
$ 385
2023
126
53
184
10
373
  1. The detailed breakdown of retirement benefit expenses recognized by foreign subsidiaries in accordance with relevant local regulations is as follows:
Administration expenses For the Three Months Ended March31
2024
2023
$ 1,026
724

(k) Income tax

  1. The components of income tax for the three months ended March 31, 2024 and 2023 were as follows:
as follows:
Current tax expenses For the three months ended
March 31,
2024
$ 4,565
2023
2,473
  1. (1) Company’s income tax return for the year 2022ad been examined by the tax authorities.

(Continued)

20

(2) The domestic subsidiaries of the Company have filed and settled their corporate income tax returns with the tax authorities up to the fiscal year 2022 as approved.

(l)Capital and other equity

Except for the following disclosure, there was no significant change in capital and other equity for the periods from January 1 to March 31, 2024 and 2023. For the related information, please refer to note 6(l) to the consolidated financial statements for the year ended December 31, 2023.

1. Retained earnings

If the Company has surplus in the annual final accounts, it shall pay taxes and donations in accordance with the law, offset cumulative losses, and then appropriate 10% as statutory surplus reserve. However, when the statutory surplus reserve has reached the Company's paidin capital, no further appropriation is required. The remaining surplus shall be appropriated or reversed as required by laws and regulations, or transferred to the special surplus reserve. If there is still surplus, together with undistributed surplus at the beginning of the period, it will be classified as distributable surplus. The Board of Directors shall propose a surplus distribution plan for approval by the shareholders' meeting, and distribute dividends to the shareholders.

Taking into account financial, operational, and business factors, the Company may distribute dividends to shareholders, which shall not be less than 10% of the distributable surplus for the current fiscal year. However, if the accumulated distributable surplus is less than 3% of the paid-in capital, no distribution shall be made. Dividends may be distributed in the form of cash dividends or stock dividends. Cash dividends shall be given priority in the distribution of earnings, but stock dividends may also be distributed. The proportion of cash dividends shall not be less than 10% of the total dividend amount.

For the distribution of dividends to shareholders in the form of cash, the Board of Directors is authorized to carry out such distribution with the approval of two-thirds or more of the attending directors and a majority of the attending directors, and to report it to the shareholders' meeting.

(i) Legal reserve

When a company incurs profit, the shareholders shall decide on the distribution of the statutory earnings reserve either by issuing new shares or by paying cash of up to 25% of the actual share capital.

(ii) Special reserve

The Company chose to apply the exemption under IFRS 1 at its initial adoption of IFRSs. Any unrealized revaluation surplus, accumulated translation adjustment, and increasing amount incurred from adopting the fair value as cost for the assets classified as investment property at the transition date. According to the Financial Supervisory Commission's Order No. 1010012865 issued on April 6, 2012, an equal amount shall be appropriated to the special surplus reserve. When using, disposing of, or reclassifying related assets, a proportionate reversal of the originally appropriated special surplus reserve may be distributed as earnings.

According to the regulations of the Financial Supervisory Commission, when the Company distributes distributable earnings, the difference between the net amount of reductions in other shareholders' equity items recorded in the current year and the balance of the special surplus reserve mentioned above shall be considered. When distributing earnings for the fiscal year 2023, the Company will allocate the current year's income and the undistributed earnings from previous periods to the special surplus reserve. When

(Continued)

21

distributing earnings for the fiscal year 2024, the Company will allocate the current year's after-tax net profit, along with items other than the current year's after-tax net profit, to the undistributed earnings and the special surplus reserve from previous periods. The Company is not allowed to distribute the amounts related to reductions in other shareholders' equity from previous periods, except for the allocation to the special surplus reserve. In the event of reversals in the amounts of reductions in other shareholders' equity in the future, earnings may be distributed based on the reversed portion. As of March 31, 2024, December 31, 2023, and March 31, 2023, the balance of the special surplus reserve is $60,074 thousand, $60,074 thousand, and $34,924 thousand, respectively.

(iii) Earnings distribution

On March 15, 2024, the Board of Directors resolved the cash dividend amount for the 2023 earnings distribution proposal. Other earnings distribution items will be discussed at the Annual General Meeting of Shareholders on June 26, 2024. Additionally, on March 24, 2023, the Board of Directors resolved the cash dividend amount for the 2022 earnings distribution proposal, with other earnings distribution items being approved at the Annual General Meeting of Shareholders on June 16, 2023. The dividends distributed to shareholders are as follows:

Cash dividends distributed to
ordinary shareholders
2023
Amount
per share
Total
amount
$ 0.31
51,554
2022 2022
Amount
per share
0.80
Total
amount
133,042

(iv) OCI accumulated in reserves

Balance at January 1, 2024
Exchange differences on foreign operations
Unrealized gains (losses) from financial
assets measured at fair value through other
comprehensive income
Balance at March 31, 2024
Balance at January 1, 2023
Exchange differences on foreign operations
Unrealized gains (losses) from financial
assets measured at fair value through other
comprehensive income
Balance at March 31, 2023
Exchange
differences on
translation of
foreign financial
statements

$ (83,104)
10,105

-
$ (72,999)
$ (55,153)
(4,176)

$ (59,329)
Unrealized gains
(losses) from
financial assets
measured at fair
value through
other
comprehensive
income
Total
(4,039)
(87,143)
10,105
(92)
(92)
(4,131)
(77,130)
(4,921)
(60,074)
(4,176)
1,402
1,402
(3,519)
(62,848)

(Continued)

22

(m) Earnings per share

For the three months ended March 31, 2024 and 2023, the Company’s earnings per share were calculated as follows:

  1. Basic earnings per share

  2. (i) Profit attributable to ordinary shareholders of the Company

Profit/(loss) of the Company for the year For the three months ended
March 31
For the three months ended
March 31
2024
$ 18,261
2023
10,597

(ii) Weighted-average number of ordinary shares

Weighted-average number of ordinary shares(thousand shares)
Earnings per share
For the three months
ended March 31
For the three months
ended March 31
2024

166,303
$ 0.11
2023
166,303
0.06

2. Diluted earnings per share

The diluted earnings per share of the Group for the fiscal year 2024 and the period from January 1, 2023, to March 31, 2023, are calculated based on the net income attributable to the equity holders of the Company and the adjusted weighted average number of ordinary shares outstanding, considering the dilutive effects of all potential ordinary shares. The calculations are as follows:

  • (i) Profit attributable to ordinary shareholders of the Company
Profit/(loss) attributable to ordinary shareholders of
the Company (basic)
ii) Weighted-average number of ordinary shares
Weighted-average number of ordinary shares
(thousand shares) (basic)
Effect of employee share bonus
Weighted-average number of ordinary shares
(thousand shares) (diluted)
Earnings per share
For the three months ended
March 31
2024
2023
$ 18,261
10,597
For the three months ended
March 31
2024
2023
166,303
166,303
64
109
166,367
166,412
$ 0.11
0.06
For the three months ended
March 31
2024
2023
$ 18,261
10,597
For the three months ended
March 31
2024
2023
166,303
166,303
64
109
166,367
166,412
$ 0.11
0.06
166,412
0.06

(ii) Weighted-average number of ordinary shares

(Continued)

23

(n) Revenue from contracts with customers

i. Disaggregation of revenue

For the three months ended March 31, 2024

Electronics
Division
Primary geographical markets
Asia
$ 114,563
America
22,117
Europe
1,302
Others
247
$ 138,229
Major products/services lines
Electronic
Components Sales
$ 138,229
Rental Income
-
Medical Equipment
Sales
-
Wine Trading
-
$ 138,229
Property
Management
Division
5,436
-
-
-
5,436
-
5,436
-
-
5,436
Medical
Equipment
Division
2,782
-
-
-
2,782
-
-
2,782
-
2,782
Wine Trading
Department
810
-
-
-

Total
-
-
-

123,591
22,117
1,302
247
810 147,257
-
-
-


-
-
-
810
810
138,229
5,436
2,782
810
147,257

For the three months ended March 31, 2023

Electronics
Division
Primary geographical markets
Asia
$ 130,621
America
19,348
Europe
2,344
Others
312
$ 152,625
Property
Management
Division
7,523
-
-
-
7,523
Medical
Equipment
Division
6,106
129
-
-
6,235
Wine Trading
Department
1,292
-
-
-
1,292
Total
145,542
19,477
2,344
312
167,675

(Continued)

24

For the three months ended March 31, 2023

Electronics
Division
Property
Management
Division
Major products/services lines
Electronic
Components Sales
$ 152,625
-
Rental Income
-
7,523
Medical Equipment
Sales
-
-
Wine Trading
-
-
$ 152,625
7,523
ii. Contract balances
March 31, 2024
Trade receivables and notes
receivable
$ 136,381
Less: allowance for
impairment
(24,600)
$ 111,781
Contract liabilities
$ 32
Property
Management
Division
Medical
Equipment
Division
Wine Trading
Department
Total
-
-
152,625
-
-
7,523
6,235
-
6,235
-
1,292
1,292
6,235
1,292
167,675
December 31, 2023
March 31, 2023
115,169
152,034
(24,378)
(27,983)
90,791
124,051
68
3,971
Medical
Equipment
Division
Wine Trading
Department
Total
-
-
152,625
-
-
7,523
6,235
-
6,235
-
1,292
1,292
6,235
1,292
167,675
December 31, 2023
March 31, 2023
115,169
152,034
(24,378)
(27,983)
90,791
124,051
68
3,971
Medical
Equipment
Division
Wine Trading
Department
Total
-
-
152,625
-
-
7,523
6,235
-
6,235
-
1,292
1,292
6,235
1,292
167,675
December 31, 2023
March 31, 2023
115,169
152,034
(24,378)
(27,983)
90,791
124,051
68
3,971
Medical
Equipment
Division
Wine Trading
Department
Total
-
-
152,625
-
-
7,523
6,235
-
6,235
-
1,292
1,292
6,235
1,292
167,675
December 31, 2023
March 31, 2023
115,169
152,034
(24,378)
(27,983)
90,791
124,051
68
3,971
Total
-
7,523
-
-
152,625
7,523
6,235
1,292
7,523 167,675
90,791 124,051
68 3,971

For details on trade receivables and allowance for impairment, please refer to note 6(c).

(o) Remunerations to employees, directors and supervisors

The Company’ s Articles of Incorporation require that earnings shall first be offset against any deficit, then, a minimum of 1% will be distributed as employee remuneration, and a maximum of 2% will be allocated as remuneration to directors. Employees who are entitled to receive the above- mentioned employee remuneration, in share or cash, include the employees of the Company’s subsidiaries who meet certain specific requirements.

For the three months ended March 31, 2024 and 2023, remuneration of employees of $240 thousand and $135 thousand, respectively, and remuneration of directors of $430 thousand and $255 thousand, respectively, were estimated on the basis of the Company’s net profit before tax, excluding the remuneration of employees and directors of each period, multiplied by the percentage of remuneration of employees and directors as specified in the Company’s articles of incorporation. Such amounts were recognized as operating expenses for the three months ended March 31, 2024 and 2023, Management is expecting that the differences, if any, between the actual distributed amounts and estimated amounts will be treated as changes in accounting estimates and will be charged to profit or loss. The number of shares to be distributed was calculated based on the closing price of the Company’s ordinary shares, one day prior to Board of Directors meeting.

(Continued)

25

The amount of employee compensation for the year 2023 as resolved by the Board of Directors is consistent with the amount estimated in the 2023 individual financial statements. However, the amount of compensation for directors and supervisors as resolved by the Board of Directors differs by $600 thousand from the amount estimated in the 2023 individual financial statements. This discrepancy is mainly due to differences in the company's accounting estimates and will be recognized in the 2024 profit and loss. In the fiscal year 2022, there was a difference of $488 thousand and $500 thousand between the amount of remuneration approved by the Board of Directors for employees, directors, and supervisors and the estimated amount accrued for the fiscal year 2022. This difference primarily arises from accounting estimates made by the Company and has been recognized in the income statement for the fiscal year 2023.

(p) Non-operating income and expenses

1. Other income

Interest income
Dividend income
For the three months ended March 31, For the three months ended March 31,
2024
$ 2,755
64
$ 2,819
2023
568
33
601
  1. Other gains and losses
Foreign exchange gains (losses)
Gains (losses) on financial assets at fair value
through profit or loss
Other
For the three months ended March 31, For the three months ended March 31,
2024
$ 4,531
5,234
43
$ 9,808
2023
(897)
7,378
(8)
6,473
  1. Finance costs
nce costs $ 9,808
6,473
$ 9,808
6,473
Interest expense For the three months ended March 31,
2024
$(84)
2023
(164)
  • (q) Financial instruments

  • Credit risk

  • (i) Credit risk exposure

The carrying amount of financial assets and contract assets represents the maximum amount exposed to credit risk.

  • (ii) Concentration of credit risk

The Group has a broad customer base and does not engage in significant transactions with any single customer. Additionally, its sales are geographically diversified. Therefore, there is no significant concentration of credit risk.

(Continued)

26

(iii) Receivables and debt securities

For credit risk exposure of trade receivables and notes receivable, please refer to note 6(c). Other financial assets at amortized cost include other receivables. All of these financial assets are considered to have low risk, and thus, the impairment provision recognized during the period was limited to 12-month expected credit losses. The fixed deposits held by the group are transacted with and settled by financial institutions that have investmentgrade ratings or above. Therefore, they are considered to have low risk. The loss allowances were determined as follows:

Balance at January 1, 2024
Balance at March 31, 2024
Balance at January 1, 2023
Balance at March 31, 2023
Other receivables
$ 36,992
$ 36,992
$ 36,992
$ 36,992

2. Liquidity risk

The following table shows the contractual maturities of financial liabilities, including estimated interest payments and excluding the impact of netting agreements.

March 31, 2024
Non-derivative financial liabilities
Floating rate instruments
Non-interest bearing liabilities
Lease liabilities(include non-
current)
December 31, 2023
Non-derivative financial liabilities
Floating rate instruments
Non-interest bearing liabilities
Lease liabilities(include non-
current)
March 31, 2023
Non-derivative financial liabilities
Floating rate instruments
Non-interest bearing liabilities
Lease liabilities(include non-
current)
Carrying
amount
Contractual
cash flows
Within 6
months
6-
12 months 12 months 1-2 years 2 -5 years
Over 5 years
$ 10,000
10,025
10,025
156,542
156,542
156,542
7,258
7,556
1,243
-
-
1,262
-
-
4,670
-
-
-
-
381
-



$
173,800
174,123
167,810

1,262

4,670
381



$ 15,000
15,143
5,095
108,230
108,230
108,230
7,521
7,864
1,186
$
130,751
131,237
114,511

10,048
-
1,213
11,261

-
-
4,766
4,766
-
-
-
-
699
-
699



$ 30,000
30,047
30,047
271,212
271,212
271,212
6,226
6,623
1,660
$
307,438
307,882
302,919

-
-
868
868

-
-
2,429
2,429
-
-
-
-
1,666
-

1,666

The Group does not expect the cash flows included in the maturity analysis to occur significantly earlier or at significantly different amounts.

(Continued)

27

3. Market risk

(i) Currency risk

The Group’s significant exposure to foreign currency risk was as follows:

Financial assets
Monetary items
USD : NTD
USD : CNY
Non-monetary items
USD
Financial liabilities
Monetary items
USD : NTD
March 31, 2024 December 31, 2023

The Group’s exposure to foreign currency risk arises from the translation of the foreign currency exchange gains and losses on cash and cash equivalents, trade and other receivables, financial assets at fair value through other comprehensive income, and trade and other payables that are denominated in foreign currency.

A strengthening (weakening) of 0.5% of the NTD against the USD, and CNY as at three months of 2024 and 2023 would have increased (decreased) the net profit after tax by $3,345 thousand and $718 thousand, and the equity by $171 thousand and $157 thousand. The analysis is performed on the same basis.

Since the Group has many kinds of functional currency, the information on foreign exchange gain (loss) on monetary items is disclosed by total amount. For the three months ended March 31, 2024 and 2023, the foreign exchange gain (loss) (including realized and unrealized portions) amounted to $4,531 thousand and $897 thousand, respectively.

(ii) Interest rate analysis

Please refer to the notes on liquidity risk management and interest rate exposure of the Group's financial assets and liabilities.

The following sensitivity analysis is based on the exposure to the interest rate risk of derivative and non-derivative financial instruments on the reporting date. Regarding assets with variable interest rates, the analysis is based on the assumption that the amount of assets outstanding at the reporting date was outstanding throughout the year. The rate of change is expressed as the interest rate increases or decreases by 0.5% when reporting to management internally, which also represents the Group management's assessment of the reasonably possible interest rate change.

If the interest rate had increased / decreased by 0.5% basis points, the Group’s net income would have increased / decreased by $10 thousand and $30 thousand for the three months ended March 31, 2024 and 2023, respectively, with all other variable factors remaining constant. This is mainly due to the Group’s borrowing at variable rates.

(iii) Other market price risk

For the three months ended March 31, 2024 and 2023, the sensitivity analyses for the changes in the securities price at the reporting date were performed using the same basis for profit or loss as illustrated below:

(Continued)

28

For the three months ended March 31,
2024
2023
Prices of securities at the
reporting date
Other
comprehensive
income after tax
Net income
Other
comprehensive
income after tax
Net income
For the three months ended March 31, For the three months ended March 31, For the three months ended March 31, For the three months ended March 31, For the three months ended March 31,
2024
2023
Net income
Other
comprehensive
income after tax
Net income
0.5% increase
$
0.5% decrease
$
83

(83)
58
(58)
80

(80)
98
(98)
  1. Fair value of financial instruments

  2. (i) Fair value hierarchy

The carrying amount and fair value of the Group’s financial assets and liabilities, including the information on fair value hierarchy, were as follows; however, except as described in the following paragraphs, for financial instruments not measured at fair value whose carrying amount is reasonably close to the fair value, and lease liabilities, disclosure of fair value information is not required:

Financial assets at fair value through
profit or loss
Shares of stock of overseas listed
companies
Beneficiary certificates
Subtotal
Financial assets at fair value through
other comprehensive income
Foreign corporate bonds
Stocks in unlisted companies
Subtotal
Financial assets measured at
amortized cost
Cash and cash equivalents
Trade receivables and notes
receivable (including related
parties)
Other receivables
Guarantee deposits paid (Recognition
of other non-current assets)
Subtotal
Total
Financial liabilities measured at
amortized cost
Bank loans
Trade payables
Other payables
Lease liabilities (including non-
current)
Guarantee deposits received
(Recognition of other non-current
liabilities)
Total
March 31, 2024 March 31, 2024 March 31, 2024
Book Value Fair Value Total
14,617
835
Level 1 Level 2
-
-
Level 3
-
-
$ 14,617
835
14,617
835
15,452 15,452 - - 15,452
42,681
16,592
-
-
42,681
16,592

-

-
42,681
16,592
59,273 - 59,273
-
59,273
579,185
111,781
18,338
319
-
-
-
-
-
-
-
-
-
-
-
-
709,623

$
784,348
15,452 59,273 74,725

$ 10,000
79,181
77,361
7,258
4,756

-
-
-
-
-

-
-
-
-
-

-
-
-
-
-

-
-
-
-
-

$
178,556

(Continued)

29

29
Financial assets at fair value through
profit or loss
Shares of stock of overseas listed
companies
Shares of stock of listed companies
Beneficiary certificates
Subtotal
Financial assets at fair value through
other comprehensive income
Foreign corporate bonds
Stocks in unlisted companies
Subtotal
Financial assets measured at
amortized cost
Cash and cash equivalents
Trade receivables and notes
receivable (including related
parties)
Other receivables
Guarantee deposits paid (Recognition
of other non-current assets)
Subtotal
Total
Financial liabilities measured at
amortized cost
Bank loans
Trade payables
Other payables
Lease liabilities (including non-
current)
Guarantee deposits received
(Recognition of other non-current
liabilities)
Total
December 31, 2023 Total
30,174
3,558
785
Book Value
$30,174
3,558
785
34,517
42,090
15,546
57,636
516,703
90,791
1,662
310
Fair Value
Level 1
30,174
3,558
785
Level 2 Level 3
-
-
-
-

-

-

-
-
-
-
-
34,517
-
-

-

-
-
-
-
34,517

42,090
15,546

57,636

57,636

-
-
-
-

-
-
-
-
609,466 - - - -

$
701,619
34,517 57,636 92,153

$15,000
75,697
32,533
7,521
4,756

-
-
-
-
-

-
-
-
-
-

-
-
-
-
-

-
-
-
-
-

$
135,507

(Continued)

30

Financial assets at fair value through
profit or loss
Shares of stock of overseas listed
companies
Shares of stock of listed companies
Beneficiary certificates
Subtotal
Financial assets at fair value
through other comprehensive
income
Foreign corporate bonds
Stocks in unlisted companies
Subtotal
Financial assets measured at
amortized cost
Cash and cash equivalents
Trade receivables and notes
receivable (including related
parties)
Other receivables
Guarantee deposits paid (Recognition
of other non-current assets)
Subtotal
Total
Financial liabilities measured at
amortized cost
Bank loans
Trade payables and notes payables
Other payables
Lease liabilities (including non-
current)
Guarantee deposits received
(Recognition of other non-current
liabilities)
Total
March 31, 2023 March 31, 2023 March 31, 2023 March 31, 2023 March 31, 2023 Total
16,464
6,396
597
23,457
39,169
16,015
Book Value Fair Value
Level 1 Level 2 Level 3
$ 16,464
6,396
597
23,457
39,169
16,015
55,184
303,505
124,051
1,922
884
16,464
6,396
597
-
-
-
-



-
-
-
-
23,457


-
-
-
-



55,184

55,184

-
-
-
-

-
-
-
-
430,362
- - - -

$
509,003
23,457 55,184 78,641

$30,000
109,541
161,671
6,226
7,763

-
-
-
-
-

-
-
-
-
-

-
-
-
-
-

-
-
-
-
-

$
315,201

(ii) Valuation techniques for financial instruments measured at fair value

A financial instrument is regarded as being quoted in an active market if quoted prices are readily and regularly available from an exchange, dealer, broker, industry group, pricing service, or regulatory agency and those prices represent actual and regularly occurring market transactions on an arm’s-length basis. Whether transactions are taking place ‘regularly’ is a matter of judgment and depends on the facts and circumstances of the market for the instrument.

Quoted market prices may not be indicative of the fair value of an instrument if the activity in the market is infrequent, the market is not well-established, only small

(Continued)

31

volumes are traded, or bid-ask spreads are very wide. Determining whether a market is active involves judgment.

Measurements of fair value of financial instruments without an active market are based on valuation technique or quoted price from a competitor. Fair value, measured by using valuation technique that can be extrapolated from either similar financial instruments or discounted cash flow method or other valuation techniques, including models, is calculated based on available market data at the reporting date.

(iii) Transfers between Level 1 and Level 2

There were no transfers from level 2 to level 1 for the three months ended March 31, 2024 and 2023.

  • (r)Financial risk management

There were no significant changes in the Group's financial risk management and policies as disclosed in note 6(r) to the consolidated financial statements for the year ended December 31, 2023.

  • (s) Capital management

Management believes that the objectives, policies and processes of capital management of the Group has been applied consistently with those described in the consolidated financial statements for the year ended December 31, 2023. Also, management believes that there were no significant changes in the Group's capital management information as disclosed for the year ended December 31, 2023. Please refer to note 6(s) to the consolidated financial statements for the year ended December 31, 2023 for further details.

7. Related-party transactions

  • (a) Names and relationships with related parties

The followings are entities that have had transactions with related party during the periods covered in the consolidated financial statements.

Name of related party Relationship with the Group
CHU-TING CORP
Lin, I-Chin

LIN, WEN-TENG

Sunrise On The Bund Hotel
(Sunrise)

PU HWUA ENTERPRISE CO.,
LTD. (Pu Hwua)

Juyang Xingye Industrial Co.,
Ltd. ( Juyang Xingye)

Juiye Enterprise Co., Ltd. (Juiye
Enterprise)
Chairman of this company is the same as the Chairman of the other
company.
Chairman of this company
Director of this company
The chairman of the subsidiary is the same as the chairman of the
Company.
The chairman of the subsidiary is the same as the chairman of the
Company.
The chairman of the Company is also a director of the subsidiary.
The chairman of the company is a director of the company.

(Continued)

32

  • (b) Significant transactions with related parties

1. Sales

The amounts of significant sales by the Group to related parties were as follows:

The amounts of significant sales by the Group to related parties were as follows: parties were as follows:
Other related parties For the three months ended
March 31,
2024
$ 814
2023

1,427

The sales price of the group to the related party is not significantly different from the general selling price. The average credit period for related parties as of March 31, 2024, and January 1 to March 31, 2023, is approximately 120 days, while for general customers, it ranges from 30 to 90 days.

2. Receivables from related parties

The receivables from related parties were as follows:

Account
Trade receivables
Relationship

Other related parties
March 31,
2024

$ 468
December
31, 2023

955
March 31,
2023
1,357

3. Payables to related parties

The payables to related parties were as follows:

Account Relationship March 31, December
March 31,
2024 31, 2023 2023
Other payables Others $ 24 108 -

4. Leases

The Group collected rental income from other related parties and affiliated companies, reporting lease income of $430 thousand and $429 thousand for the year ended December 31, 2024, and for the period from January 1 to March 31, 2023, respectively. As of March 31, 2024, December 31, 2023, and March 31, 2023, related rental deposits amounted to $405 thousand.

In November 2023, the Group rented an office building from the Key management person to be used as its headquarter. A five-year lease contract was signed, in which the rental fee is determined based on nearby office rental rates. The total value of the contract was $5,309 thousand. For the three months ended March 31, 2024, the Group recognized the amounts of $32 thousand and $39 thousand respectively as interest expenses. As of March 31, 2024 the balance of lease liabilities amounted to $3,809 thousand and $4,550 thousand respectively.

5. Prepayments

Account
Prepayments
Relationship

Others- Sunrise
March 31,
2024

$ -
December
31, 2023

-
March 31,
2023
1,864

(c) Others

In case of registering real estate under the name of other related parties, please refer to Note 6(7) for details.

(Continued)

33

(d) Key management personnel compensation

Key management personnel compensation comprised:

Key management personnel compensation comprised:
Short-term employee benefits
Post-employment benefits
For the three months
ended March 31,
2024
$ 6,504
38
$ 6,542
2023
3,688
24
3,712

8. Assets pledged as security

The carrying amounts of assets pledged as security were as follows:

Assets pledged as
security
Property, plant and
equipment
Investment property
Liabilities
secured by
pledge

Long-term
borrowings
Long-term
borrowings
March 31,
2024
$231,531
50,330
**$281,861 **
December
31, 2023

232,298

50,605

282,903
March 31,
2023
234,656
51,428
286,084

9. Significant Commitments and Contingencies

  • (a) Unrecognized contractual commitments

As of March 31, 2024, December 31, 2023, and March 31, 2023, the detailed amounts of the contract prices for equipment and construction projects entered into by the Group with suppliers are as follows::

Signed-contract
Paid-price
March 31,
2024

$ 33,391
$ 28,555
December
31, 2023

13,764
9,038
March 31,
2023
29,783
16,096

(b) To comply with the organic renewal and industrial transformation and upgrading of the Jiashan Economic and Technological Development Industrial Park, the subsidiary Zhejiang Rectron signed a relocation compensation agreement with Jiashan Economic Development Zone Asset Management Co., Ltd. on September 22, 2023. The total compensation amount is approximately $691,875 thousand (RMB 161,653 thousand). It was agreed that Zhejiang Rectron should complete the equipment relocation and vacate the premises by June 30, 2024. The subsidiary Zhejiang Rectron received a partial compensation payment of approximately $356,849 thousand (RMB 80,827 thousand) in October 2023.

10. Losses due to major disasters: none

11. Subsequent events:

On May 9, 2024, the subsidiary Zhejiang Rectron's Board of Directors approved the purchase of a four-story industrial building from Jiashan Economic Development Zone Asset Management Co., Ltd., authorizing the Chairman to handle the transaction within a specified amount.

(Continued)

34

12. Others

(a)A summary of employee benefits, depreciation, and amortization, by function, is as follows:

By function
By item
For the three months ended March 31, For the three months ended March 31, For the three months ended March 31, For the three months ended March 31,
2024 2023
Cost of
sales
Operating
expenses
Total Cost of
sales
Operating
expenses
Total
Employee benefits
Salary
Labor and health insurance
Pension
Others
Depreciation
Amortization
4,873
370
136
171
9,538
120
22,843
1,873
1,282
1,101
2,673
640
27,716
2,243
1,418
1,272
12,211
760
4,744
353
130
177
10,051
329
27,317
1,811
979
1,178
3,102
653
32,061
2,164
1,109
1,355
13,153
982

(b)Seasonality of operations

The Group's operations were not affected by seasonality or cyclicality factors.

13. Other disclosure items

  • (a) Information on significant transaction:

The followings were the information on significant transactions required by the “Regulations Governing the Preparation of Financial Reports by Securities Issuers” for the Group for the three months ended March 31, 2024:

  1. Lending to other parties:

==> picture [426 x 107] intentionally omitted <==

----- Start of picture text -----

Highest
balance Collateral
of Actual Transaction
financing usage Range of Purposes amount for Reasons for Allowance
to other amount interest of fund business short-term for bad Individual Maximum
Number Name of lender borrower Name of Account name Related party parties during the balance Ending during period the during the period rates financing borrower for the two parties between financing debt Item Value loan limits funding financing limit of fund
period
1 Rectron China CHU-TING Other Yes 60,002 44,800 44,800 - 2 - Operation - - - 159,850 199,812
receivables (note 3) (note 4) Requirements
Note 1: For business transactions with counterparties, the business transaction amount is determined based on the cumulative
sales (or purchases) amount between the two parties over the preceding twelve months.
Note 2: According to our policy, the calculation for the maximum total amount of loans granted are as follows:
Rectron Electronics (China)
----- End of picture text -----

Individual counterparty funding limit = Shareholders' equity x 40% = $399,624 thousand x 40% = $159,850 thousand. The maximum funding limit for an individual counterparty = Shareholders' equity x 50% = $399,624 thousand x 50% = $199,812 thousand.

Note 3: Already eliminated during the preparation of the consolidated financial statements. Note 4: (1) Business transaction with counterparts exists.

  • (2) Short-term funding is necessary.

  • Guarantees and endorsements for other parties: None.

  • Information regarding securities held at the reporting date (subsidiaries, associates and joint ventures not included):

(Amounts in Thousands of New Taiwan Dollar) (Amounts in Thousands of New Taiwan Dollar) (Amounts in Thousands of New Taiwan Dollar) (Amounts in Thousands of New Taiwan Dollar) (Amounts in Thousands of New Taiwan Dollar)
Company holding securities Security type
and name
Relationship
with the
Company
Account March 31, 2024 Remark
Shares Carrying
value
Percentage
of ownership
(%)


Market value
( or net value)
The Company Stock - Sunny Bank - Non-current financial
assets at fair value
through other
comprehensive income
1,515,198 16,592 0.05%
16,592
The Company Corporate bonds – Apple - Non-current financial
assets at fair value
through other
comprehensive income
-
25,846
-% 25,846
The Company Corporate bonds – AT&T - Non-current financial
assets at fair value
through other
comprehensive income
-
9,426
-% 9,426

(Continued)

35

35
Company holding securities
The Company
The Company
CHU-TING
CHU-TING
Security type
and name
Relationship
with the
Company
Account March 31, 2024 Remark
Shares Carrying
value
Percentage
of ownership
(%)

Market value
( or net value)
Corporate bonds – Pfizer - Non-current financial
assets at fair value
through other
comprehensive income
- 4,157 - % 4,157
Corporate bonds – SocGen - Non-current financial
assets at fair value
through other
comprehensive income
- 3,252 - % 3,252
Fund - Yuanta High Dividend 0056 - Current financial assets
at fair value through
profit or loss
21,000 835 -% 835
Stock - LMT - Current financial assets
at fair value through
profit or loss
1,000 14,617 -% 14,617
  1. Information regarding purchase or sale of securities for the period exceeding 300 million or 20% of the Company’s paid-in capital: None.

  2. Information regarding acquisition of real estate exceeding 300 million or 20% of the Company’s paid-in capital:

(Amounts in Thousands of New Taiwan Dollar) (Amounts in Thousands of New Taiwan Dollar) (Amounts in Thousands of New Taiwan Dollar) (Amounts in Thousands of New Taiwan Dollar) (Amounts in Thousands of New Taiwan Dollar) (Amounts in Thousands of New Taiwan Dollar)
Name of
company
Type of
property
Transac
tion date
Transaction
amount
Amount
actually
payable
Counter-
party
Nature of
relationship
For tr ansactions involving related parties, the
**previous transfer information **
Price
reference
Purpose
of
Acquisit
ion and
**Usage **
Other
terms
owner Relationship
with the Issuer
Transfer
Date
amount
The
Company
Land and
Building
2024.1.10 -
(Note 1)
-
(Note 1)
CHU-
TING
Parent-
subsidiary
relationship
- - - - Appraisal private
use
None
CHU-
TING
Land 2024.1.10 -
(Note 1)
-
(Note 1)
The
Company
Parent-
subsidiary
relationship
- - - - Appraisal private
use
None

Note 1: A joint development agreement for the land located at Parcel No. 145, Pei Bo Section, Tucheng District, New Taipei City, Taiwan, has been signed with the following distribution ratio: Landowner (the company): approximately 45.66%, Developer (CHUTING): approximately 54.34%. The final joint development ratio shall be subject to approval by the competent authority.

  1. Information regarding receivables from disposal of real estate exceeding 300 million or 20% of the Company’s paid-in capital:
6. Information regarding receivables from disposal of real estate exceeding 300 million or 20% of
the Company’s paid-in capital:
6. Information regarding receivables from disposal of real estate exceeding 300 million or 20% of
the Company’s paid-in capital:
6. Information regarding receivables from disposal of real estate exceeding 300 million or 20% of
the Company’s paid-in capital:
6. Information regarding receivables from disposal of real estate exceeding 300 million or 20% of
the Company’s paid-in capital:
6. Information regarding receivables from disposal of real estate exceeding 300 million or 20% of
the Company’s paid-in capital:
6. Information regarding receivables from disposal of real estate exceeding 300 million or 20% of
the Company’s paid-in capital:
6. Information regarding receivables from disposal of real estate exceeding 300 million or 20% of
the Company’s paid-in capital:
6. Information regarding receivables from disposal of real estate exceeding 300 million or 20% of
the Company’s paid-in capital:
6. Information regarding receivables from disposal of real estate exceeding 300 million or 20% of
the Company’s paid-in capital:
6. Information regarding receivables from disposal of real estate exceeding 300 million or 20% of
the Company’s paid-in capital:
6. Information regarding receivables from disposal of real estate exceeding 300 million or 20% of
the Company’s paid-in capital:
6. Information regarding receivables from disposal of real estate exceeding 300 million or 20% of
the Company’s paid-in capital:
6. Information regarding receivables from disposal of real estate exceeding 300 million or 20% of
the Company’s paid-in capital:
(Amounts in Thousands of New Taiwan Dollar)
Name of
company
Type of
property
Transacti
on date
Acquisition
date
Book
value
Transacti
on
amount
Amount
actually
received
Gain from
disposal
Counter-
party
Nature
of
relatio
nship
Purpose of
disposal
Price
reference
Other
terms
Zhejiang
Rectron
Land,
Buildings,
and
Structures
2023.9.22 90.08 177,168
(Note 1)
691,875
(Note 2)
356,849
(Note 3)
(Note 4) Jiashan
Economic
Development
Assets
Management
Co., Ltd.
None To align
with
organic
renewal and
industry
transformati
on and
upgrading
Appraisal
Report
(Note 5)
Note 1:RMB40,925 thousand
Note 2:RMB161,653 thousand
Note 3:RMB80,827 thousand
Note 4: Profit and loss shall be confirmed after all relocation procedures are completed.
Note 5: According to the agreed terms, after signing the relocation compensation agreement with Zhejiang Rectron, 50% of the total
compensation will be received. Additionally, within 20 days after the completion of equipment relocation and factory vacating by
June 30, 2024, 30% of the total compensation will be received. The remaining 20% of the total compensation will be received within
20 days after the cancellation of land and property certificates.
  1. Information regarding related-party purchases and/or sales exceeding 100 million or 20% of the Company’s paid-in capital: None.

(Continued)

36

  1. Information regarding receivables from related parties exceeding 100 million or 20% of the Company’s paid-in capital:
(Amounts in Thousands of New Taiwan Dollar) (Amounts in Thousands of New Taiwan Dollar) (Amounts in Thousands of New Taiwan Dollar) (Amounts in Thousands of New Taiwan Dollar)
Company name Related party Nature of relationship Balance as
September 30,
2023
Turnover
O verdue Amount received in
subsequent period

Allowance
for bad
debts
Amount Action taken
Rectron China The Company Parent-subsidiary relationship 100,247 2.66% 26,314 Collection 19,951 -

Note: The amount had been offset in the consolidated financial statements.

  1. Information regarding trading in derivative financial instruments: None.

  2. Significant transactions and business relationship between the parent company and its subsidiaries for the three months ended March 31, 2024:

(Amounts in Thousands of New Taiwan Dollar)

No.
(Note 1)
Company name Counterparty Relationship
(Note 2)
Intercompany transactions Intercompany transactions
Account Amount Terms Percentage of total
consolidated net sales
or assets
0 Rectron Ltd. Rectron China 1 Operating cost 59,223 Calculated with finished product cost plus
agreedprofit.
40%
0 Rectron Ltd. Rectron China 1 Trade payables 100,247 Adjusted according to the overall funding
situation between the parent and subsidiary
companies, with a term of 120 days as
stipulated in the agreement.
4%
0 Rectron Ltd. REEI 1 Operating revenue 13,585 Calculated with finished product cost plus
agreedprofit.
9%
0 Rectron Ltd. REEI 1 Account receivable
9,172
Adjusted according to the overall funding
situation between the parent and subsidiary
companies, with a term of 120 days as
stipulated in the agreement.
-%
1 Rectron China Zhejiang Rectron 3 Operating cost 50,186 Calculated with finished product cost plus
agreedprofit.
34%

Note 1: Companies are numbered as follows: Parent company 0 Subsidiary starting from 1

Note 2: The relationships between transaction parties are numbered as follows: Parent company and subsidiary 1

Subsidiary and parent company 2 Subsidiary and subsidiary 3

(b) Information on investments:

The followings are the information on investees for the three months ended March 31, 2024:

(Amounts in Thousands of New Taiwan Dollar)

Name of
investor
Name of
investee
Location Main businesses Original
am
investment
ount
Balance as of March 31, 2024 as of March 31, 2024 Net income
(loss) of the
investee



Investment
income (loss)
recognised by
the Company
Remark
March 31,
2024
December 31
2023
,
Shares
Percentage
Carrying
value
The Company REEI USA Sales of rectifiers, etc. Electronic
components
142,264 142,264 205,000 100.00% 16,417 601 601
The Company Rectron China Hong
Kong
Sales of rectifiers, etc. Electronic
components
607,273 607,273 20,000 100.00% 399,624 989 989
The Company CHU-TING Taiwan Wholesale of tobacco and alcohol
products and manufacturing and sales
of medical equipment.

109,987
109,987 14,500,000 100.00% 158,504 1,628 1,628

Note: The amount had been offset in the consolidated financial statements.

  • (c) Information on investment in Mainland China:

(Amounts in Thousands of New Taiwan Dollar)

Investee Main businesses
and products
Total amount
of paid-in
capital
Method of
investment
Accumulated
outflow of
investment
from Taiwan as
of January 1,
2024
Inves tment Accumulated
outflow of
investment
from Taiwan as
of March 31,
2024
Net income
(losses) of the
investee
Percentage of
ownership
Investment
income (loss)
recognized
Carrying value
as of March 31,
2024
Accumulated
inward remittance
of earnings as of
March 31, 2024

Outflow
Inflow
Zhejiang Rectron Manufacturing and sales of
rectifiers and other electronic
components.
409,029
USD12,000
NOTE 1(3) 409,029
USD12,000
- - 409,029
USD12,000
5,477 100.00% 5,477 278,571 -

(Continued)

37

  • (d) Upper limit on investment in Mainland China:
(Amounts in Thousands of New Taiwan Dollar) (Amounts in Thousands of New Taiwan Dollar)
Accumulated investment in Mainland China
as of March 31, 2024
Investment amount authorized by
Investment Commission, MOEA
Upper limit on investment
384,000
USD 12,000
511,040
USD 15,970
1,051,390

Note 1: Investment methods are categorized into the following three types, simply indicated by their types:

  • (1)Direct investment in mainland China.

(2)Investment in Mainland China through a third-party company in another region (please specify the investment company in that third region).

  • (3)Others method.

Note 2: In the investment gains/losses recognized in this period column:

  • (1)If it is under preparation and there are no investment gains/losses yet, it should be noted.

  • (2)The basis for recognizing investment gains/losses is the financial statements audited and certified by the certified public accountant of the Taiwan parent company.

  • Note 3: According to the "Principles for Reviewing Investment or Technical Cooperation in Mainland China," there are limits to the amount of investment.

Equity net worth × 60% = $1,752,317 thousand × 60% = $1,051,390 thousand.

(e) Significant transactions:

The significant inter-company transactions with the subsidiary in Mainland China, which were eliminated in the preparation of consolidated financial statements, are disclosed in “Information on significant transactions”.

  • (f) Major shareholders

Unit: Share

(f) Major shareholders Unit: Sha
Shareholding
Shareholder’s Name
Shares Percentage
Juiye EnterpriseCo.,Ltd. 42,788,288 25.72%
Bigwig Perfect International Co.,
Ltd.
38,141,792 22,93%

Note: The shareholder information in this table is provided by the Taiwan Depository & Clearing Corporation (TDCC) and is based on the calculation of the total number of common shares and preferred shares held by shareholders, excluding treasury shares, as of the last business day of each quarter. The data includes shareholders whose holdings account for more than 5% of the total shares outstanding. Please note that there may be differences between the reported share capital in the company's financial statements and the actual number of shares held by shareholders, due to different calculation methods or other factors.

14. Segment information

(a) General information

The consolidated company has four reporting segments: Electronics, Real Estate Investment, Medical Equipment, and Wine Trading. The Diode segment is engaged in the manufacturing and sales of various rectifiers and other semiconductor components. The Real Estate Investment segment is engaged in the business of leasing office buildings and factories. The Medical Equipment segment is engaged in the business of buying and selling and manufacturing masks. The Wine Trading segment is engaged in the business of trading red and white wines.

The reporting segments of the consolidated company are strategic business units that provide different products and services. As each strategic business unit requires different technology and marketing strategies, they need to be managed separately.

  • (b) Information of profit or loss, assets, liabilities, basis and adjustments of which of departments to be reported.

(Continued)

38

The consolidated company uses the departmental pre-tax profit (excluding non-recurring gains and losses and exchange gains and losses) reviewed by the chief operating decision-maker in the internal management report as the basis for resource allocation and performance evaluation by the management. Since income tax, non-recurring gains and losses, and exchange gains and losses are managed on a group basis, the consolidated company does not allocate income tax expenses (benefits), non-recurring gains and losses, and exchange gains and losses to the reporting segments. In addition, not all significant non-cash items, other than depreciation and amortization, are included in the income statement of all reporting segments. The amounts reported are consistent with the reports used by the operating decision-makers.

The information and adjustments for the operating segments of the consolidated company are as follows:

The Group’s operating segment information and reconciliation are as follows:

For the three
months ended
March 31, 2024
Revenue
Revenue from
external
customers
Intersegment
revenues
Total
revenue
Reportable
segment profit
or loss
For the three
months ended
March 31, 2023
Revenue
Revenue from
external
customers
Intersegment
revenues
Total
revenue
Reportable
segment profit
or loss
Electronics
Department
$ 138,229
121,848
$ 260,077
$ 17,775
Electronics
Department
$ 152,625
123,644
$ 276,269
$ 6,722
Property
Management
Division
5,436
-
5,436
3,424
Property
Management
Division
7,523
-
7,523
4,702
Medical
Devices
Division
2,782
172
2,954
1,037
Medical
Devices
Division
6,235
325
6,560
1,181
Wine
Trading
Department
810
-
810
590
Wine
Trading
Department
1,292
-
1,292
465
Reconciliation
and
elimination
-
(122,020)
(122,020)
-
Reconciliation
and
elimination
-
(123,969)
(123,969)
-
Total
147,257
-
147,257
22,826
Total
167,675
-
167,675
13,070

(Continued)